# Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment

> **NCT03833830** · — · COMPLETED · sponsor: **Dr. med. Katja Hatz** · enrollment: 40 (actual)

## Conditions studied

- Neovascular Age-related Macular Degeneration

## Interventions

- **DIAGNOSTIC_TEST:** Optical Coherence Tomography angiography (OCTA)

## Key facts

- **NCT ID:** NCT03833830
- **Lead sponsor:** Dr. med. Katja Hatz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-07
- **Primary completion:** 2019-04-02
- **Final completion:** 2019-05-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833830, "Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03833830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*